Myasthenia gravis is a chronic autoimmune disorder, where your own immune system disrupts the communication between nerves ...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the enrollment of the first patient in the new PPD(TM) CorEvitas(TM) Myasthenia Gravis (MG) Registry. This ...
The EPIC study will evaluate treatment with IMAAVY™ versus efgartigimod in adults with gMG and will include a treatment-switch arm The Company also announced new data from the pivotal Vibrance-MG ...
Your eyes offer a crucial window into your overall health, revealing early signs of serious conditions like diabetes, heart ...
Thank you, operator. Hello, and welcome, everyone. Today's earnings call will be led by Dr. Samantha Du, Zai Lab's Founder, CEO and Chairperson. She will be joined by Josh Smiley, President and Chief ...
The third quarter 2025 financial results and business update will be discussed during a conference call and webcast presentation today at 1:30 pm CET/8:30 am ET. A webcast of the live call and replay ...
New phase 3 data show meaningful improvement in antibody-negative myasthenia gravis, for which treatment options are limited ...
Myasthenia gravis is a chronic condition that causes muscles to tire and weaken easily. For example, if you have myasthenia gravis, you may notice that during a meal, your jaw muscles become tired and ...
Two open-label extension studies show that the FcRn blocker nipocalimab has durable efficacy and sustained symptom control ...
Takenobu Y, Kikuchi T, Ishikawa D, et al. Rozanolixizumab as rescue therapy in triple seronegative refractory generalized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback